Study experiences in people with neuroendocrine tumors
Part of Cancer clinical trials.
This trial asks adults with a neuroendocrine tumor to share their study experiences through surveys or interviews. It may help researchers understand what supports or challenges people face during care and research.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 years or older
- Have been diagnosed with a neuroendocrine tumor
- Be able to understand the study and sign a consent form
- Not be enrolled in another research study at the same time
- Not be pregnant or breastfeeding
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at neuroendocrine tumors by collecting tissue (when available) and tracking how the disease behaves over time. It may help researchers better understand these cancers, including rare cases of adrenocortical cancer.
This trial looks at how well octreotide microspheres work for people with neuroendocrine tumors that cannot be removed by surgery or have spread to other parts of the body. It aims to help doctors understand the real-world benefits of this treatment.
This study sets up a national registry to collect information about people with neuroendocrine tumors. It helps researchers understand these cancers better and improve care over time.
This study looks at patterns in what adults with neuroblastoma experience during treatment and follow-up visits. It may help researchers understand what patients go through so care and support can improve.
This study asks adults with newly diagnosed testicular cancer about their experiences before any cancer treatment starts. It may help researchers understand what patients need and how trial care affects real life.
This trial follows people with medullary thyroid cancer to better understand their experiences. You may join if you have this diagnosis, are 18 or older, and are not taking another experimental drug.
Hear when a new Neuroendocrine Tumors trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.